{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:22:03Z","timestamp":1787678523365,"version":"build-2784847793"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110116","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:33:42Z","timestamp":1781739222000},"page":"110116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Arsenic trioxide triggers ferroptosis in neuroblastoma via USF1\/GPX4 axis"],"prefix":"10.1016","volume":"180","author":[{"given":"Yuhan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10357","key":"10.1016\/j.bioorg.2026.110116_bb0005","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0140-6736(22)01541-0","article-title":"Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study","volume":"400","author":"Ni","year":"2022","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.bioorg.2026.110116_bb0010","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.neuron.2022.07.012","article-title":"Neuroblastoma: when differentiation goes awry","volume":"110","author":"Zeineldin","year":"2022","journal-title":"Neuron"},{"issue":"18","key":"10.1016\/j.bioorg.2026.110116_bb0015","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1182\/blood-2008-11-190827","article-title":"Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory","volume":"113","author":"Jing","year":"2009","journal-title":"Blood"},{"issue":"9579","key":"10.1016\/j.bioorg.2026.110116_bb0020","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.bioorg.2026.110116_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237069","article-title":"Synthetic heterocyclic derivatives as kinase inhibitors tested for the treatment of neuroblastoma","volume":"26","author":"Musumeci","year":"2021","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.bioorg.2026.110116_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143494","article-title":"Oral metronomic maintenance therapy can improve survival in high-risk neuroblastoma patients not treated with ASCT or anti-GD2 antibodies","volume":"13","author":"Sun","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110116_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28390","article-title":"Association between end-induction response according to the revised international neuroblastoma response criteria (INRC) and outcome in high-risk neuroblastoma patients","volume":"67","author":"Barr","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110116_bb0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12887-023-04258-w","article-title":"Prognostic factors for intermediate- or high-risk neuroblastomas in children in China","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Pediatr."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110116_bb0045","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1007\/s12035-024-04501-0","article-title":"Pharmacologically targeting Ferroptosis and Cuproptosis in neuroblastoma","volume":"62","author":"Liu","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2026.110116_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1423869","article-title":"Ferroptosis and its relationship with cancer","volume":"12","author":"Su","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2026.110116_bb0055","article-title":"Ferroptosis and its relationship with cancer","volume":"12","author":"Su","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110116_bb0060","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ng.3899","article-title":"Neuroblastoma is composed of two super-enhancer-associated differentiation states","volume":"49","author":"van Groningen","year":"2017","journal-title":"Nat. Genet."},{"issue":"7679","key":"10.1016\/j.bioorg.2026.110116_bb0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"issue":"7664","key":"10.1016\/j.bioorg.2026.110116_bb0070","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110116_bb0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41419-021-03790-w","article-title":"MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma","volume":"12","author":"Lu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110116_bb0080","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/0008-5472.CAN-20-1641","article-title":"MYCN-amplified neuroblastoma is addicted to Iron and vulnerable to inhibition of the system xc\u2212\/glutathione Axis","volume":"81","author":"Floros","year":"2021","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110116_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc3526","article-title":"Neuroblastoma: developmental biology, cancer genomics and immunotherapy","volume":"13","author":"Cheung","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110116_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041301","article-title":"Ferroptosis inducers kill mesenchymal stem cells affected by neuroblastoma","volume":"15","author":"Li","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2026.110116_bb0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40364-020-00229-w","article-title":"Novel insights on targeting ferroptosis in cancer therapy","volume":"8","author":"Zuo","year":"2020","journal-title":"Biomark. Res."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110116_bb0100","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17425247.2024.2372363","article-title":"Harness arsenic in medicine: current status of arsenicals and recent advances in drug delivery","volume":"21","author":"Liu","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110116_bb0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10534-022-00371-y","article-title":"Arsenic in medicine: past, present and future","volume":"36","author":"Paul","year":"2023","journal-title":"Biometals"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110116_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.11.013","article-title":"Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2026.110116_bb0115","first-page":"0696","article-title":"Mutation in the Unrearranged PML allele confers resistance to arsenic trioxide in acute Promyelocytic leukemia","volume":"8","author":"Yu","year":"2025","journal-title":"Research (Wash D C)."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110116_bb0120","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1158\/2159-8290.CD-23-0453","article-title":"Structural basis of PML-RARA Oncoprotein targeting by arsenic unravels a cysteine rheostat controlling PML body assembly and function","volume":"13","author":"Bercier","year":"2023","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110116_bb0125","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3727\/096504021X16184815905096","article-title":"Excellent early outcomes of combined chemotherapy with arsenic trioxide for stage 4\/M neuroblastoma in children: a multicenter nonrandomized controlled trial","volume":"28","author":"Li","year":"2021","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110116_bb0130","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1186\/s12885-024-12884-5","article-title":"Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110116_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13716","article-title":"Arsenic trioxide induces ferroptosis in neuroblastoma by mediating GPX4 transcriptional inhibition","volume":"17","author":"Su","year":"2024","journal-title":"Clin. Transl. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110116_bb0140","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1007\/s11033-022-07497-9","article-title":"Arsenic trioxide increases apoptosis of SK-N-BE (2) cells partially by inducing GPX4-mediated ferroptosis","volume":"49","author":"Feng","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bioorg.2026.110116_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110116_bb0150","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/cas.14760","article-title":"Combination of tumor necrosis factor-\u03b1 and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells","volume":"112","author":"Huang","year":"2020","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110116_bb0155","first-page":"976","article-title":"Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1","volume":"3","author":"Mabe","year":"2022","journal-title":"Nat. Can."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110116_bb0160","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110116_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102694","article-title":"Targeting iron-sulfur clusters in cancer: opportunities and challenges for ferroptosis-based therapy","volume":"15","author":"Lee","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110116_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4302","article-title":"Iron-sulfur cluster deficiency can be sensed by IRP2 and regulates iron homeostasis and sensitivity to ferroptosis independent of IRP1 and FBXL5","volume":"7","author":"Terzi","year":"2021","journal-title":"Sci. Adv."},{"issue":"23","key":"10.1016\/j.bioorg.2026.110116_bb0175","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","article-title":"SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation","volume":"83","author":"Zhang","year":"2023","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110116_bb0180","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1517\/13543784.2015.1021003","article-title":"Ezatiostat hydrochloride for the treatment of myelodysplastic syndromes","volume":"24","author":"Mahadevan","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110116_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081908","article-title":"Cannabinol inhibits cellular proliferation, invasion, and angiogenesis of neuroblastoma via novel miR-34a\/tRiMetF31\/PFKFB3 Axis","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"Pt 1","key":"10.1016\/j.bioorg.2026.110116_bb0190","article-title":"A novel GSH depletor for simultaneous ferroptosis and cuproptosis activation in hepatocellular carcinoma","volume":"243","author":"Yang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110116_bb0195","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2025.04.052","article-title":"Resveratrol induces ferroptosis in triple-negative breast cancer through NEDD4L-mediated GPX4 ubiquitination and degradation","volume":"235","author":"Zhang","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110116_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70213","article-title":"Paeonol inhibits cell growth by inducing Ferroptosis in human glioma cells","volume":"14","author":"Li","year":"2026","journal-title":"Pharmacol. Res. Perspect."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110116_bb0205","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1016\/j.apsb.2025.08.003","article-title":"Arsenic trioxide-based nanoparticles for enhanced chemotherapy by activating pyroptosis","volume":"15","author":"Wang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110116_bb0210","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3727\/096504021X16184815905096","article-title":"Excellent early outcomes of combined chemotherapy with arsenic trioxide for stage 4\/M neuroblastoma in children: a multicenter nonrandomized controlled trial","volume":"28","author":"Li","year":"2021","journal-title":"Oncol. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110116_bb0215","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3892\/or.2012.1852","article-title":"Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion","volume":"28","author":"You","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bioorg.2026.110116_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2019.110063","article-title":"Toxic effects of arsenic trioxide on spermatogonia are associated with oxidative stress, mitochondrial dysfunction, autophagy and metabolomic alterations","volume":"190","author":"Chen","year":"2020","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.bioorg.2026.110116_bb0225","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7072917","article-title":"The differential expression of mitochondrial function-associated proteins and antioxidant enzymes during bovine herpesvirus 1 infection: a potential mechanism for virus infection-induced oxidative mitochondrial dysfunction","volume":"2019","author":"Fu","year":"2019","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110116_bb0230","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","article-title":"Resolving the role of lipoxygenases in the initiation and execution of Ferroptosis","volume":"4","author":"Shah","year":"2018","journal-title":"ACS Cent. Sci."},{"issue":"17","key":"10.1016\/j.bioorg.2026.110116_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172726","article-title":"Molecular mechanisms of Ferroptosis and relevance to cardiovascular disease","volume":"11","author":"Xie","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110116_bb0240","article-title":"Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110116_bb0245","article-title":"USF1 transcriptionally regulates UGT1A3 and promotes lung adenocarcinoma progression by regulating Neurotrophin signaling pathway","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110116_bb0250","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.17945","article-title":"USF1 regulated circPRDM4 modulates tumorigenesis and immune escape in chemoresistant cervical cancer","volume":"28","author":"Zhang","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bioorg.2026.110116_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111700","article-title":"PUS1 facilitates cell migration in clear cell renal cell carcinoma through the promotion of mRNA pseudouridylation and the stabilization of the SMOX gene","volume":"130","author":"Chen","year":"2025","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110116_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113194","article-title":"SEZ6L2, regulated by USF1, accelerates the growth and metastasis of breast cancer","volume":"417","author":"Chen","year":"2022","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110116_bb0265","article-title":"Role of USF1 in activating CYBA transcription and influencing NADPH-ROS-mediated oxidative stress and lipid accumulation in non-alcoholic fatty liver disease","volume":"1870","author":"Zhuang","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110116_bb0270","doi-asserted-by":"crossref","first-page":"865","DOI":"10.56434\/j.arch.esp.urol.20247708.122","article-title":"USF1 silencing reduces Ferroptosis resistance in prostate Cancer cells","volume":"77","author":"Gao","year":"2024","journal-title":"Arch. Esp. Urol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110116_bb0275","first-page":"114","article-title":"Super enhancers define regulatory subtypes and cell identity in neuroblastoma","volume":"2","author":"Gartlgruber","year":"2021","journal-title":"Nat. Can."},{"key":"10.1016\/j.bioorg.2026.110116_bb0280","article-title":"Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity","volume":"14","author":"Damico","year":"2023","journal-title":"Front. Immunol."},{"issue":"43","key":"10.1016\/j.bioorg.2026.110116_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq4617","article-title":"Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance","volume":"8","author":"Manas","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.110116_bb0290","first-page":"3","article-title":"Mesenchymal neuroblastoma cells are undetected by current mRNA marker panels: the development of a specific neuroblastoma mesenchymal minimal residual disease panel","author":"Van Wezel","year":"2019","journal-title":"JCO Precis. Oncol."},{"issue":"29","key":"10.1016\/j.bioorg.2026.110116_bb0295","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz3440","article-title":"ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression","volume":"6","author":"Shi","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110116_bb0300","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1158\/0008-5472.CAN-21-1621","article-title":"Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors","volume":"82","author":"Westerhout","year":"2022","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110116_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111455","article-title":"Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory","volume":"41","author":"Yuan","year":"2022","journal-title":"Cell Rep."},{"issue":"7664","key":"10.1016\/j.bioorg.2026.110116_bb0310","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:43:36Z","timestamp":1787676216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":62,"alternative-id":["S0045206826006528"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110116","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arsenic trioxide triggers ferroptosis in neuroblastoma via USF1\/GPX4 axis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110116"}}